RE: RE: RE: Press releases Long time ago I worked as audtior for a company... sometime I found wrong things just by relax and plausible thinking through the whole story .....
- all of the presentations and information seemed to point to a full success of dunavetide
- question:"why was there no insider action buying or selling" during the final weeks before the final announcement?
- was there never a conversation between the scientists and the clinics telling them how the test's are progressing? (normally scientists and clinics keep informing and updating)
impression? if the NPC management was not buying in the last months they probably had information that the drug will fail (most likely insiders will know if it is a success and would acquire more shares)
I remember still the conversation of the CEO with seekingalpha, it left the impression that the clinical tests point to total success...did the CEO already know about the possible results?
https://seekingalpha.com/article/902931-straight-talk-from-allon-therapeutics-ceo-gordon-mccauley
now everybody can make the own analysis. This were just my thoughts